Form 8-K BridgeBio Pharma, Inc. For: Jan 14

Go back to Form 8-K BridgeBio Pharma, Inc. For: Jan 14

BridgeBio issues $632.5 million convertible notes due 2033

January 21, 2026 4:14 PM UTC

BridgeBio Pharma Inc. (NASDAQ: BBIO) issued $632.5 million in convertible senior notes due 2033 through a private offering to qualified institutional buyers on January 21, 2026, according to a company statement.

The notes carry a 0.75% annual interest rate and mature on February 1, 2033. Interest payments occur semiannually on February 1 and August 1, beginning August 1, 2026.... More